Dr J J Misiewicz and Dr Sheila L Wailer (MRC Gastroenterology Research Unit, Central Middlesex Hospital, London) The Effect of 5-hydroxytryptamine on the Human Colon in vivo and in vitro The effect of 5-hydroxytryptamine (5HT, serotonin) on the colon is of physiological and of clinical interest. The physiological role of 5HT is still undecided, although the alimentary tract contains large quantities and it has been shown to potentiate the peristaltic reflex in animals (Bulbring & Crema 1958) . Alimentary symptoms are common in the carcinoid syndrome and serotonin may bh the cause of the abdominal cramps and watery diarrhoea of which patients with carcinoid complain.
Wehave investigatedtheeffect of 5HT on human alimentary tract both in vivo and in vitro. In 39 patients, intraluminal pressures were measured in the pelvic colon with tubes introduced through a sigmoidoscope, while pressures in the proximal colon and in other parts of the gut were recorded with radiotelemetering capsules (Rowlands & Wolff 1960) . The effect on motility of 4 0 mg of 5-hydroxytryptamine creatinine sulphate given intravenously over eight minutes was measured and compared with control, placebo and postinjection periods of equal duration. The pressure records were analysed and the results expressed in terms of a motility index (MI). The in vitro studies were carried out on strips of human alimentary muscle from surgical resection specimens using standard pharmacological techniques. Both methods have been described fully elsewhere ( Misiewicz et al. 1966) . 5HT inhibited colonic muscle both in vivo and in vitro. Fig 1 shows a rapid inhibition of motor activity in the proximal colon, sigmoid and rectum by 4 mg of serotonin. The results of colonic studies are summarized in Table 1 . Analysis of the pressure tracings showed a highly significant fall in the MI in all the parts of the colon that were studied. The placebo had no significant effect, except in the rectum, but there the direction of change was opposite to that produced by the 5HT. Table 2 In vitro studies on colonic and small intestinal muscle In vitro, serotonin (0 04-5 0 pg/ml) inhibited all the muscle strips from the tranverse and descending colon (Fig 2) but cwcal muscle gave variable results (Table 2 ). Pharmacological analysis suggested that the site of action of 5HT was directly on the muscle cell. In contrast to the colon, upper and lower small intestine was consistently stimulated by serotonin in vivo (Table 1 ) and in vitro ( Table 2 ). The site of action was again found to be directly on the smooth muscle cell.
In vivo, the same dose of 5HT given over the same period of time stimulated the small intestine, but inhibited the right and left colon, while in vitro pharmacological analysis suggested that the drug acted directly on the smooth muscle. The present in vitro results confirm the findings of Bennett (1965) and of Fishlock & Parks (1963) . Inhibition by serotonin of the motor activity of the left colon is now generally accepted (Schmid & Kinzlmeier 1959 , Fink & Friedman 1960 , Ramorino et al. 1965 ), although some workers report contraction of the right colon (Ramorino et al. 1965) . This variation in the response of the right colon may be due to differences in the rate of drug administration and different selection of subjects. Variations in the response of the colon to 5HT in the basal or stimulated state may also be important.
If the pharmacological effects of serotonin resemble the action of 5HT released in the body, then on the basis of the above results patients with the carcinoid syndrome who have diarrh(ea and an elevated urinary 5HIAA should have hyperactivity of the small intestine and hypoactivity of the colon. This was so in a 56-year-old woman with carcinoid, facial flushing, diarrhcea and elevated urinary excretion of 5HIAA, whose motility record revealed gross small intestinal hyperactivity, while the colon was inactive.
The flush of carcinoid is now thought to be due to a release of a bradykinin (Robertson et al. 1962 , Oates et al. 1966 . Treatment with the serotonin antagonist methysergide relieves the diarrhoea while having no effect on the flush (Peart & Robertson 1961) . It seems likely, therefore, that serotonin is a factor in the production of symptoms in the carcinoid syndrome. Neostigmine has a parasympatheticomimetic action due to its ability to inhibit cholinesterase. It is a 'physiological' stimulus in so far as it probably accentuates the effect on the colon of naturally occurring stimuli. The intrasigmoid pressure patterns were measured for a period of one hour before and after the administration of 1 mg intramuscularly of-neostigmine both in the healthy human subject and in patients with diverticulosis. These pressure patterns were
